---
document_datetime: 2025-12-29 11:42:33
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/thorinane.html
document_name: thorinane.html
version: success
processing_time: 0.1076488
conversion_datetime: 2025-12-31 05:23:09.025203
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Thorinane

[RSS](/en/individual-human-medicine.xml/66489)

##### Lapsed

This medicine's authorisation has lapsed

enoxaparin sodium Medicine Human Lapsed

On Monday, 12 January 2026, between 07:00 and 10:00 CET (Amsterdam time), this website will be unavailable due to scheduled maintenance.

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)
- [News on Thorinane](#news-on)
- [Related content](#related-content-711)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

The marketing authorisation for Thorinane has lapsed because it has not been marketed in the European Union in the three years following the granting of theOn 15 September 2019, the marketing authorisation of Thorinane (enoxaparin sodium) ceased to be valid in the European Union (EU). The cessation of validity is due to the fact that the marketing authorisation holder, Techdow Pharma Netherlands B.V., had not marketed Thorinane in the EU since its initial marketing authorisation.

In accordance with provisions of the sunset clause, the marketing authorisation of the medicinal product lapsed as the product had not been marketed in any of the EU Member States within three years of its initial authorisation. Techdow Pharma Netherlands B.V. confirmed that the product had not been marketed due to business reasons.

Thorinane was granted marketing authorisation in the EU on 15 September 2016 for prophylaxis of thromboembolic disorders of venous origin. The marketing authorisation was initially valid for a 5-year period. Thorinane was a duplicate application to Inhixa, which is marketed in several EU countries. The marketing authorisation holder will maintain the marketing authorisation for Inhixa.

The European Public Assessment Report (EPAR) for Thorinane is updated to indicate that the marketing authorisation is no longer valid. authorisation.

Thorinane : EPAR - Summary for the public

Reference Number: EMA/511753/2016

English (EN) (551.84 KB - PDF)

**First published:** 26/10/2016

**Last updated:** 24/10/2019

[View](/en/documents/overview/thorinane-epar-summary-public_en.pdf)

[Other languages (22)](#file-language-dropdown-261)

български (BG) (633.52 KB - PDF)

**First published:**

26/10/2016

**Last updated:**

24/10/2019

[View](/bg/documents/overview/thorinane-epar-summary-public_bg.pdf)

español (ES) (520.81 KB - PDF)

**First published:**

26/10/2016

**Last updated:**

24/10/2019

[View](/es/documents/overview/thorinane-epar-summary-public_es.pdf)

čeština (CS) (613.91 KB - PDF)

**First published:**

26/10/2016

**Last updated:**

24/10/2019

[View](/cs/documents/overview/thorinane-epar-summary-public_cs.pdf)

dansk (DA) (548.17 KB - PDF)

**First published:**

26/10/2016

**Last updated:**

24/10/2019

[View](/da/documents/overview/thorinane-epar-summary-public_da.pdf)

Deutsch (DE) (552.44 KB - PDF)

**First published:**

26/10/2016

**Last updated:**

24/10/2019

[View](/de/documents/overview/thorinane-epar-summary-public_de.pdf)

eesti keel (ET) (518.74 KB - PDF)

**First published:**

26/10/2016

**Last updated:**

24/10/2019

[View](/et/documents/overview/thorinane-epar-summary-public_et.pdf)

ελληνικά (EL) (603.4 KB - PDF)

**First published:**

26/10/2016

**Last updated:**

24/10/2019

[View](/el/documents/overview/thorinane-epar-summary-public_el.pdf)

français (FR) (521.25 KB - PDF)

**First published:**

26/10/2016

**Last updated:**

24/10/2019

[View](/fr/documents/overview/thorinane-epar-summary-public_fr.pdf)

hrvatski (HR) (541.21 KB - PDF)

**First published:**

26/10/2016

**Last updated:**

24/10/2019

[View](/hr/documents/overview/thorinane-epar-summary-public_hr.pdf)

italiano (IT) (519.63 KB - PDF)

**First published:**

26/10/2016

**Last updated:**

24/10/2019

[View](/it/documents/overview/thorinane-epar-summary-public_it.pdf)

latviešu valoda (LV) (580.43 KB - PDF)

**First published:**

26/10/2016

**Last updated:**

24/10/2019

[View](/lv/documents/overview/thorinane-epar-summary-public_lv.pdf)

lietuvių kalba (LT) (543.47 KB - PDF)

**First published:**

26/10/2016

**Last updated:**

24/10/2019

[View](/lt/documents/overview/thorinane-epar-summary-public_lt.pdf)

magyar (HU) (575.06 KB - PDF)

**First published:**

26/10/2016

**Last updated:**

24/10/2019

[View](/hu/documents/overview/thorinane-epar-summary-public_hu.pdf)

Malti (MT) (582.55 KB - PDF)

**First published:**

26/10/2016

**Last updated:**

24/10/2019

[View](/mt/documents/overview/thorinane-epar-summary-public_mt.pdf)

Nederlands (NL) (520.42 KB - PDF)

**First published:**

26/10/2016

**Last updated:**

24/10/2019

[View](/nl/documents/overview/thorinane-epar-summary-public_nl.pdf)

polski (PL) (581.66 KB - PDF)

**First published:**

26/10/2016

**Last updated:**

24/10/2019

[View](/pl/documents/overview/thorinane-epar-summary-public_pl.pdf)

português (PT) (520.53 KB - PDF)

**First published:**

26/10/2016

**Last updated:**

24/10/2019

[View](/pt/documents/overview/thorinane-epar-summary-public_pt.pdf)

română (RO) (541.52 KB - PDF)

**First published:**

26/10/2016

**Last updated:**

24/10/2019

[View](/ro/documents/overview/thorinane-epar-summary-public_ro.pdf)

slovenčina (SK) (580.54 KB - PDF)

**First published:**

26/10/2016

**Last updated:**

24/10/2019

[View](/sk/documents/overview/thorinane-epar-summary-public_sk.pdf)

slovenščina (SL) (574.09 KB - PDF)

**First published:**

26/10/2016

**Last updated:**

24/10/2019

[View](/sl/documents/overview/thorinane-epar-summary-public_sl.pdf)

Suomi (FI) (519.25 KB - PDF)

**First published:**

26/10/2016

**Last updated:**

24/10/2019

[View](/fi/documents/overview/thorinane-epar-summary-public_fi.pdf)

svenska (SV) (519.77 KB - PDF)

**First published:**

26/10/2016

**Last updated:**

24/10/2019

[View](/sv/documents/overview/thorinane-epar-summary-public_sv.pdf)

## Product information

Thorinane : EPAR - Product Information

English (EN) (3.77 MB - PDF)

**First published:** 26/10/2016

**Last updated:** 24/10/2019

[View](/en/documents/product-information/thorinane-epar-product-information_en.pdf)

[Other languages (24)](#file-language-dropdown-893)

български (BG) (7.74 MB - PDF)

**First published:**

26/10/2016

**Last updated:**

24/10/2019

[View](/bg/documents/product-information/thorinane-epar-product-information_bg.pdf)

español (ES) (3.57 MB - PDF)

**First published:**

26/10/2016

**Last updated:**

24/10/2019

[View](/es/documents/product-information/thorinane-epar-product-information_es.pdf)

čeština (CS) (6.42 MB - PDF)

**First published:**

26/10/2016

**Last updated:**

24/10/2019

[View](/cs/documents/product-information/thorinane-epar-product-information_cs.pdf)

dansk (DA) (4.26 MB - PDF)

**First published:**

26/10/2016

**Last updated:**

24/10/2019

[View](/da/documents/product-information/thorinane-epar-product-information_da.pdf)

Deutsch (DE) (4.52 MB - PDF)

**First published:**

26/10/2016

**Last updated:**

24/10/2019

[View](/de/documents/product-information/thorinane-epar-product-information_de.pdf)

eesti keel (ET) (3.29 MB - PDF)

**First published:**

26/10/2016

**Last updated:**

24/10/2019

[View](/et/documents/product-information/thorinane-epar-product-information_et.pdf)

ελληνικά (EL) (7.12 MB - PDF)

**First published:**

26/10/2016

**Last updated:**

24/10/2019

[View](/el/documents/product-information/thorinane-epar-product-information_el.pdf)

français (FR) (3.81 MB - PDF)

**First published:**

26/10/2016

**Last updated:**

24/10/2019

[View](/fr/documents/product-information/thorinane-epar-product-information_fr.pdf)

hrvatski (HR) (3.33 MB - PDF)

**First published:**

26/10/2016

**Last updated:**

24/10/2019

[View](/hr/documents/product-information/thorinane-epar-product-information_hr.pdf)

íslenska (IS) (3.32 MB - PDF)

**First published:**

26/10/2016

**Last updated:**

24/10/2019

[View](/is/documents/product-information/thorinane-epar-product-information_is.pdf)

italiano (IT) (3.67 MB - PDF)

**First published:**

26/10/2016

**Last updated:**

24/10/2019

[View](/it/documents/product-information/thorinane-epar-product-information_it.pdf)

latviešu valoda (LV) (5.64 MB - PDF)

**First published:**

26/10/2016

**Last updated:**

24/10/2019

[View](/lv/documents/product-information/thorinane-epar-product-information_lv.pdf)

lietuvių kalba (LT) (3.28 MB - PDF)

**First published:**

26/10/2016

**Last updated:**

24/10/2019

[View](/lt/documents/product-information/thorinane-epar-product-information_lt.pdf)

magyar (HU) (10.98 MB - PDF)

**First published:**

26/10/2016

**Last updated:**

24/10/2019

[View](/hu/documents/product-information/thorinane-epar-product-information_hu.pdf)

Malti (MT) (5.87 MB - PDF)

**First published:**

26/10/2016

**Last updated:**

24/10/2019

[View](/mt/documents/product-information/thorinane-epar-product-information_mt.pdf)

Nederlands (NL) (3.7 MB - PDF)

**First published:**

26/10/2016

**Last updated:**

24/10/2019

[View](/nl/documents/product-information/thorinane-epar-product-information_nl.pdf)

norsk (NO) (3.14 MB - PDF)

**First published:**

26/10/2016

**Last updated:**

24/10/2019

[View](/no/documents/product-information/thorinane-epar-product-information_no.pdf)

polski (PL) (5.85 MB - PDF)

**First published:**

26/10/2016

**Last updated:**

24/10/2019

[View](/pl/documents/product-information/thorinane-epar-product-information_pl.pdf)

português (PT) (3.21 MB - PDF)

**First published:**

26/10/2016

**Last updated:**

24/10/2019

[View](/pt/documents/product-information/thorinane-epar-product-information_pt.pdf)

română (RO) (3.55 MB - PDF)

**First published:**

26/10/2016

**Last updated:**

24/10/2019

[View](/ro/documents/product-information/thorinane-epar-product-information_ro.pdf)

slovenčina (SK) (5.69 MB - PDF)

**First published:**

26/10/2016

**Last updated:**

24/10/2019

[View](/sk/documents/product-information/thorinane-epar-product-information_sk.pdf)

slovenščina (SL) (5.41 MB - PDF)

**First published:**

26/10/2016

**Last updated:**

24/10/2019

[View](/sl/documents/product-information/thorinane-epar-product-information_sl.pdf)

Suomi (FI) (3.34 MB - PDF)

**First published:**

26/10/2016

**Last updated:**

24/10/2019

[View](/fi/documents/product-information/thorinane-epar-product-information_fi.pdf)

svenska (SV) (3.23 MB - PDF)

**First published:**

26/10/2016

**Last updated:**

24/10/2019

[View](/sv/documents/product-information/thorinane-epar-product-information_sv.pdf)

**Latest procedure affecting product information:** T/0003 05/09/2017

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

Thorinane : EPAR - All Authorised presentations

English (EN) (480.85 KB - PDF)

**First published:** 26/10/2016

**Last updated:** 24/10/2019

[View](/en/documents/all-authorised-presentations/thorinane-epar-all-authorised-presentations_en.pdf)

[Other languages (24)](#file-language-dropdown-722)

български (BG) (506.81 KB - PDF)

**First published:**

26/10/2016

**Last updated:**

24/10/2019

[View](/bg/documents/all-authorised-presentations/thorinane-epar-all-authorised-presentations_bg.pdf)

español (ES) (463.14 KB - PDF)

**First published:**

26/10/2016

**Last updated:**

24/10/2019

[View](/es/documents/all-authorised-presentations/thorinane-epar-all-authorised-presentations_es.pdf)

čeština (CS) (528.54 KB - PDF)

**First published:**

26/10/2016

**Last updated:**

24/10/2019

[View](/cs/documents/all-authorised-presentations/thorinane-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (484.14 KB - PDF)

**First published:**

26/10/2016

**Last updated:**

24/10/2019

[View](/da/documents/all-authorised-presentations/thorinane-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (486.14 KB - PDF)

**First published:**

26/10/2016

**Last updated:**

24/10/2019

[View](/de/documents/all-authorised-presentations/thorinane-epar-all-authorised-presentations_de.pdf)

eesti keel (ET) (460.2 KB - PDF)

**First published:**

26/10/2016

**Last updated:**

24/10/2019

[View](/et/documents/all-authorised-presentations/thorinane-epar-all-authorised-presentations_et.pdf)

ελληνικά (EL) (519.17 KB - PDF)

**First published:**

26/10/2016

**Last updated:**

24/10/2019

[View](/el/documents/all-authorised-presentations/thorinane-epar-all-authorised-presentations_el.pdf)

français (FR) (463.22 KB - PDF)

**First published:**

26/10/2016

**Last updated:**

24/10/2019

[View](/fr/documents/all-authorised-presentations/thorinane-epar-all-authorised-presentations_fr.pdf)

hrvatski (HR) (466.95 KB - PDF)

**First published:**

26/10/2016

**Last updated:**

24/10/2019

[View](/hr/documents/all-authorised-presentations/thorinane-epar-all-authorised-presentations_hr.pdf)

íslenska (IS) (459.6 KB - PDF)

**First published:**

26/10/2016

**Last updated:**

24/10/2019

[View](/is/documents/all-authorised-presentations/thorinane-epar-all-authorised-presentations_is.pdf)

italiano (IT) (460.12 KB - PDF)

**First published:**

26/10/2016

**Last updated:**

24/10/2019

[View](/it/documents/all-authorised-presentations/thorinane-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (490.85 KB - PDF)

**First published:**

26/10/2016

**Last updated:**

24/10/2019

[View](/lv/documents/all-authorised-presentations/thorinane-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (477.9 KB - PDF)

**First published:**

26/10/2016

**Last updated:**

24/10/2019

[View](/lt/documents/all-authorised-presentations/thorinane-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (485.97 KB - PDF)

**First published:**

26/10/2016

**Last updated:**

24/10/2019

[View](/hu/documents/all-authorised-presentations/thorinane-epar-all-authorised-presentations_hu.pdf)

Malti (MT) (491.95 KB - PDF)

**First published:**

26/10/2016

**Last updated:**

24/10/2019

[View](/mt/documents/all-authorised-presentations/thorinane-epar-all-authorised-presentations_mt.pdf)

Nederlands (NL) (459.74 KB - PDF)

**First published:**

26/10/2016

**Last updated:**

24/10/2019

[View](/nl/documents/all-authorised-presentations/thorinane-epar-all-authorised-presentations_nl.pdf)

norsk (NO) (459.36 KB - PDF)

**First published:**

26/10/2016

**Last updated:**

24/10/2019

[View](/no/documents/all-authorised-presentations/thorinane-epar-all-authorised-presentations_no.pdf)

polski (PL) (489.46 KB - PDF)

**First published:**

26/10/2016

**Last updated:**

24/10/2019

[View](/pl/documents/all-authorised-presentations/thorinane-epar-all-authorised-presentations_pl.pdf)

português (PT) (461.42 KB - PDF)

**First published:**

26/10/2016

**Last updated:**

24/10/2019

[View](/pt/documents/all-authorised-presentations/thorinane-epar-all-authorised-presentations_pt.pdf)

română (RO) (480.21 KB - PDF)

**First published:**

26/10/2016

**Last updated:**

24/10/2019

[View](/ro/documents/all-authorised-presentations/thorinane-epar-all-authorised-presentations_ro.pdf)

slovenčina (SK) (487.86 KB - PDF)

**First published:**

26/10/2016

**Last updated:**

24/10/2019

[View](/sk/documents/all-authorised-presentations/thorinane-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (479.16 KB - PDF)

**First published:**

26/10/2016

**Last updated:**

24/10/2019

[View](/sl/documents/all-authorised-presentations/thorinane-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (459.6 KB - PDF)

**First published:**

26/10/2016

**Last updated:**

24/10/2019

[View](/fi/documents/all-authorised-presentations/thorinane-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (461.33 KB - PDF)

**First published:**

26/10/2016

**Last updated:**

24/10/2019

[View](/sv/documents/all-authorised-presentations/thorinane-epar-all-authorised-presentations_sv.pdf)

## Product details

Name of medicine Thorinane Active substance enoxaparin sodium International non-proprietary name (INN) or common name enoxaparin sodium Therapeutic area (MeSH) Venous Thromboembolism Anatomical therapeutic chemical (ATC) code B01AB05

### Pharmacotherapeutic group

Antithrombotic agents

### Therapeutic indication

Thorinane is indicated for adults for:

- Prophylaxis of venous thromboembolism, particularly in patients undergoing orthopaedic, general or oncological surgery.

- Prophylaxis of venous thromboembolism in patients bedridden due to acute illnesses including acute heart failure, acute respiratory failure, severe infections, as well as exacerbation of rheumatic diseases causing immobilisation of the patient (applies to strengths of 40 mg/0.4 mL).

- Treatment of deep vein thrombosis (DVT), complicated or uncomplicated by pulmonary embolism.

- Treatment of unstable angina and non Q wave myocardial infarction, in combination with acetylsalicylic acid (ASA).

- Treatment of acute ST segment elevation myocardial infarction (STEMI) including patients who will be treated conservatively or who will later undergo percutaneous coronary angioplasty (applies to strengths of 60 mg/0.6 mL, 80 mg/0.8 mL, and 100 mg/1 mL).

- Blood clot prevention in the extracorporeal circulation during haemodialysis.

Prevention and treatment of various disorders related to blood clots in adults.

## Authorisation details

EMA product number EMEA/H/C/003795

Biosimilar

This is a biosimilar medicine, which is a biological medicine highly similar to another already approved biological medicine called the 'reference medicine'. For more information, see [Biosimilar medicines](/node/68323) .

Marketing authorisation holder

Pharmathen S.A.

Techdow Pharma Netherlands B. V.

Opinion adopted 20/07/2016 Marketing authorisation issued 14/09/2016 Lapse of marketing authorisation 15/09/2019 Revision 2

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

Thorinane : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (523.92 KB - PDF)

**First published:** 10/08/2017

**Last updated:** 24/10/2019

[View](/en/documents/procedural-steps-after/thorinane-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf)

## Initial marketing authorisation documents

Thorinane : EPAR - Public assessment report

Adopted

Reference Number: EMA/536972/2016

English (EN) (1.82 MB - PDF)

**First published:** 26/10/2016

**Last updated:** 24/10/2019

[View](/en/documents/assessment-report/thorinane-epar-public-assessment-report_en.pdf)

CHMP summary of positive opinion for Thorinane

Adopted

Reference Number: EMA/CHMP/482415/2016

English (EN) (532.74 KB - PDF)

**First published:** 22/07/2016

**Last updated:** 24/10/2019

[View](/en/documents/smop-initial/chmp-summary-positive-opinion-thorinane_en.pdf)

#### News on Thorinane

[Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 18-21 July 2016](/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-18-21-july-2016) 22/07/2016

#### Related content

- [Clinical data](https://clinicaldata.ema.europa.eu/web/cdp/home?p_p_id=cdpdossierviewportlet_WAR_cdpdossierviewportlet=0=maximized=view=column-3=2=EMEAHC0037950000) (initial marketing authorisation)

**This page was last updated on** 24/10/2019

## Share this page

[Back to top](#main-content)